Yasser Mohammed Hassanain Elsayed

Egyptian Ministry of Health, Egypt

Title: Brugada Syndrome in Pulmonary Embolism-Extremely Rare Presentation with Gradual Disappearance despite Later Conversions (Yasser's Conversions) and Yasser's Coving

Biography

Yasser Mohammed Hassanain Elsayed is a distinguished scientist, critical care physician, cardiologist, and independent researcher at the Egyptian Ministry of Health. He has published 155 scientific articles and introduced 26 original innovations, including multiple eponymous signs, phenomena, maneuvers, methods, tests, syndromes, and procedures. He has been an international speaker at 37 conferences, reviewed 327 articles for 105 journals and 2 conferences, and served as an honorary editor for 275 journals and 13 conference organizing committees. Additionally, he has instructed in 14 official and 131 non-official training programs and contributed to 28 conference abstracts. Dr. Elsayed has authored 51 COVID-19–related publications, earned over 186 excellence certificates, and has been nominated for prestigious awards such as the Breakthrough Prize and Einstein Prize. His most notable contributions include the Wavy Triple and Double ECG Signs (Yasser’s Sign), Graded and Passing Phenomena (Yasser’s Phenomenon), Yasser’s Maneuver in Psychogenic Coma, Yasser’s Method, Yasser’s Stressor Test and Syndrome, Sinusoidal Atrial Fibrillation (Yasser’s Fibrillation), and numerous other procedures and criteria, significantly advancing cardiology, critical care, and electrocardiographic research.

Abstract

Brugada syndrome (BrS) is an uncommon genetic disorder accountable for 4-12% SCDs due to ventricular fibrillation. Brugada phenocopy (BrP) is a category of clinically diverse entities causing identical Brugada-like electrocardiographic patterns to actual Brugada syndrome (BrS). Till now, there has been no ECG decision even with application of the new criteria in differentiation between BrS and BrP. Acute pulmonary embolism (PE) is a known serious cardiovascular and respiratory disease. A scarce reports supporting Brugada syndrome post-acute respiratory SARS-CoV-2 (COVID-19) infection have been recorded. Case presentation: A 43-year-old, golden-furniture painter, married male Egyptian heavy smoker patient was admitted to the hospital with pleural chest pain, fever, tachypnea, and tachycardia. He was managed in the ICU for pulmonary embolism, Brugada syndrome, and pneumonia. Conclusion: Acute pulmonary embolism is a new, rare presentation and sequel of Brugada syndrome. Conversions (Yasser's Conversions) from Brugada syndrome type 1 to mixed type with right reversal post-COVID-19 pneumonia and acute pulmonary embolism is an innovative finding. The Coving Radiological Sign (Yasser's Coving Sign) is also a new radiological sign that is parallel to the electrocardiographic coving configuration of Brugada syndrome. Fever is a predisposing factor and an ominous sign for Brugada syndrome. Brugada syndrome and acute pulmonary embolism are a new description of post-COVID-19 pneumonia.